Tags

Type your tag names separated by a space and hit enter

Dedicated linear accelerator radiosurgery for trigeminal neuralgia: a single-center experience in 179 patients with varied dose prescriptions and treatment plans.
Int J Radiat Oncol Biol Phys. 2011 Sep 01; 81(1):225-31.IJ

Abstract

PURPOSE

Dedicated linear accelerator radiosurgery (D-LINAC) has become an important treatment for trigeminal neuralgia (TN). Although the use of gamma knife continues to be established, few large series exist using D-LINAC. The authors describe their results, comparing the effects of varied target and dose regimens.

METHODS AND MATERIALS

Between August 1995 and January 2008, 179 patients were treated with D-LINAC radiosurgery. Ten patients (5.58%) had no clinical follow-up. The median age was 74.0 years (range, 32-90 years). A total of 39 patients had secondary or atypical pain, and 130 had idiopathic TN. Initially, 28 patients received doses between 70 and 85 Gy, with the 30% isodose line (IDL) touching the brainstem. Then, using 90 Gy, 82 consecutive patients were treated with a 30% IDL and 59 patients with a 50% IDL tangential to the pons.

RESULTS

Of 169 patients, 134 (79.3%) experienced significant relief at a mean of 28.8 months (range, 5-142 months). Average time to relief was 1.92 months (range, immediate to 6 months). A total of 31 patients (19.0%) had recurrent pain at 13.5 months. Of 87 patients with idiopathic TN without prior procedures, 79 (90.8%) had initial relief. Among 28 patients treated with 70 Gy and 30% IDL, 18 patients (64.3%) had significant relief, and 10 (35.7%) had numbness. Of the patients with 90 Gy and 30% IDL at the brainstem, 59 (79.0%) had significant relief and 48.9% had numbness. Among 59 consecutive patients with similar dose but the 50% isodoseline at the brainstem, 49 patients (88.0%) had excellent/good relief. Numbness, averaging 2.49 on a subjective scale of 1 to 5, was experienced by 49.7% of the patients,

CONCLUSIONS

Increased radiation dose and volume of brainstem irradiation may improve clinical outcomes with the trade-off of trigeminal dysfunction. Further study of the implications of dose and target are needed to optimize outcomes and to minimize complications.

Authors+Show Affiliations

Department of Neurosurgery, UCLA Medical Center, West Los Angeles Veteran's Administration Hospital, Los Angeles, CA, USA.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

21236592

Citation

Smith, Zachary A., et al. "Dedicated Linear Accelerator Radiosurgery for Trigeminal Neuralgia: a Single-center Experience in 179 Patients With Varied Dose Prescriptions and Treatment Plans." International Journal of Radiation Oncology, Biology, Physics, vol. 81, no. 1, 2011, pp. 225-31.
Smith ZA, Gorgulho AA, Bezrukiy N, et al. Dedicated linear accelerator radiosurgery for trigeminal neuralgia: a single-center experience in 179 patients with varied dose prescriptions and treatment plans. Int J Radiat Oncol Biol Phys. 2011;81(1):225-31.
Smith, Z. A., Gorgulho, A. A., Bezrukiy, N., McArthur, D., Agazaryan, N., Selch, M. T., & De Salles, A. A. (2011). Dedicated linear accelerator radiosurgery for trigeminal neuralgia: a single-center experience in 179 patients with varied dose prescriptions and treatment plans. International Journal of Radiation Oncology, Biology, Physics, 81(1), 225-31. https://doi.org/10.1016/j.ijrobp.2010.05.058
Smith ZA, et al. Dedicated Linear Accelerator Radiosurgery for Trigeminal Neuralgia: a Single-center Experience in 179 Patients With Varied Dose Prescriptions and Treatment Plans. Int J Radiat Oncol Biol Phys. 2011 Sep 1;81(1):225-31. PubMed PMID: 21236592.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Dedicated linear accelerator radiosurgery for trigeminal neuralgia: a single-center experience in 179 patients with varied dose prescriptions and treatment plans. AU - Smith,Zachary A, AU - Gorgulho,Alessandra A, AU - Bezrukiy,Nikita, AU - McArthur,David, AU - Agazaryan,Nzhde, AU - Selch,Michael T, AU - De Salles,Antonio A F, Y1 - 2011/01/13/ PY - 2010/02/08/received PY - 2010/05/04/revised PY - 2010/05/04/accepted PY - 2011/1/18/entrez PY - 2011/1/18/pubmed PY - 2011/9/29/medline SP - 225 EP - 31 JF - International journal of radiation oncology, biology, physics JO - Int J Radiat Oncol Biol Phys VL - 81 IS - 1 N2 - PURPOSE: Dedicated linear accelerator radiosurgery (D-LINAC) has become an important treatment for trigeminal neuralgia (TN). Although the use of gamma knife continues to be established, few large series exist using D-LINAC. The authors describe their results, comparing the effects of varied target and dose regimens. METHODS AND MATERIALS: Between August 1995 and January 2008, 179 patients were treated with D-LINAC radiosurgery. Ten patients (5.58%) had no clinical follow-up. The median age was 74.0 years (range, 32-90 years). A total of 39 patients had secondary or atypical pain, and 130 had idiopathic TN. Initially, 28 patients received doses between 70 and 85 Gy, with the 30% isodose line (IDL) touching the brainstem. Then, using 90 Gy, 82 consecutive patients were treated with a 30% IDL and 59 patients with a 50% IDL tangential to the pons. RESULTS: Of 169 patients, 134 (79.3%) experienced significant relief at a mean of 28.8 months (range, 5-142 months). Average time to relief was 1.92 months (range, immediate to 6 months). A total of 31 patients (19.0%) had recurrent pain at 13.5 months. Of 87 patients with idiopathic TN without prior procedures, 79 (90.8%) had initial relief. Among 28 patients treated with 70 Gy and 30% IDL, 18 patients (64.3%) had significant relief, and 10 (35.7%) had numbness. Of the patients with 90 Gy and 30% IDL at the brainstem, 59 (79.0%) had significant relief and 48.9% had numbness. Among 59 consecutive patients with similar dose but the 50% isodoseline at the brainstem, 49 patients (88.0%) had excellent/good relief. Numbness, averaging 2.49 on a subjective scale of 1 to 5, was experienced by 49.7% of the patients, CONCLUSIONS: Increased radiation dose and volume of brainstem irradiation may improve clinical outcomes with the trade-off of trigeminal dysfunction. Further study of the implications of dose and target are needed to optimize outcomes and to minimize complications. SN - 1879-355X UR - https://www.unboundmedicine.com/medline/citation/21236592/Dedicated_linear_accelerator_radiosurgery_for_trigeminal_neuralgia:_a_single_center_experience_in_179_patients_with_varied_dose_prescriptions_and_treatment_plans_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0360-3016(10)00805-9 DB - PRIME DP - Unbound Medicine ER -